Colgate-Palmolive (CL) Holdings Increased by Tiaa Fsb
Tiaa Fsb grew its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 74,773 shares of the company’s stock after buying an additional 1,903 shares during the period. Tiaa Fsb’s holdings in Colgate-Palmolive were worth $5,006,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. DF Dent & Co. Inc. increased its position in shares of Colgate-Palmolive by 7.1% during the second quarter. DF Dent & Co. Inc. now owns 12,125 shares of the company’s stock worth $786,000 after purchasing an additional 800 shares in the last quarter. Hugh Johnson Advisors LLC increased its position in Colgate-Palmolive by 8.0% in the 2nd quarter. Hugh Johnson Advisors LLC now owns 10,861 shares of the company’s stock valued at $704,000 after acquiring an additional 801 shares during the period. West Oak Capital LLC increased its position in Colgate-Palmolive by 3.2% in the 3rd quarter. West Oak Capital LLC now owns 27,049 shares of the company’s stock valued at $1,811,000 after acquiring an additional 830 shares during the period. Heritage Way Advisors LLC increased its position in Colgate-Palmolive by 2.8% in the 2nd quarter. Heritage Way Advisors LLC now owns 31,733 shares of the company’s stock valued at $2,057,000 after acquiring an additional 875 shares during the period. Finally, Stokes Capital Advisors LLC increased its position in Colgate-Palmolive by 4.1% in the 2nd quarter. Stokes Capital Advisors LLC now owns 22,125 shares of the company’s stock valued at $1,434,000 after acquiring an additional 880 shares during the period. 74.95% of the stock is owned by institutional investors.
NYSE CL opened at $64.52 on Friday. The company has a debt-to-equity ratio of -34.49, a quick ratio of 0.74 and a current ratio of 1.06. Colgate-Palmolive has a 12-month low of $61.28 and a 12-month high of $77.91. The company has a market cap of $54.36 billion, a price-to-earnings ratio of 20.95, a price-to-earnings-growth ratio of 2.87 and a beta of 0.72.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 15th. Shareholders of record on Friday, October 19th will be given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.60%. The ex-dividend date of this dividend is Thursday, October 18th. Colgate-Palmolive’s payout ratio is 58.54%.
In other Colgate-Palmolive news, COO Noel R. Wallace sold 44,625 shares of the business’s stock in a transaction that occurred on Wednesday, August 1st. The stock was sold at an average price of $66.22, for a total transaction of $2,955,067.50. Following the transaction, the chief operating officer now owns 235,026 shares in the company, valued at approximately $15,563,421.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Philip G. Shotts sold 462 shares of the business’s stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $30,977.10. Following the transaction, the vice president now owns 41,250 shares in the company, valued at approximately $2,765,812.50. The disclosure for this sale can be found here. Insiders have sold a total of 395,779 shares of company stock worth $26,108,856 in the last quarter. 1.02% of the stock is currently owned by insiders.
CL has been the topic of several recent research reports. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Friday, October 5th. Wells Fargo & Co dropped their price target on Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research report on Wednesday. Citigroup dropped their price target on Colgate-Palmolive from $70.00 to $68.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 31st. Argus restated a “buy” rating and issued a $75.00 price target (up previously from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Finally, Stifel Nicolaus dropped their price target on Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a research report on Monday, July 23rd. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $70.79.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Read More: Understanding each part of a balance sheet
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.